UPDATE: On May 31, Stem Cells, Inc. announced that it is abruptly ending the Pathway trial, despite the encouraging results below.

I remember talking with Christopher Reeve at his estate in Pound Ridge, New York, in September 2002, a year following the 9/11 disaster that changed the world. He wanted to talk about a different kind of change — his view that a cure for paralysis was imminent and embryonic stem cells would play a central role. He was angry that congressional support was lacking.

Now, finally, human stem cell trials for those of us with SCI and other neurological diseases are in progress and yielding promising results.